Overview of Fungal Identification Methods and Strategies

Published on 08/02/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 12966 times

Overview of Fungal Identification Methods and Strategies

Objectives

1. Define the terms mycology, saprophytic, dermatophyte, and polymorphic, dimorphic, and thermally dimorphic fungi.

2. Define and differentiate superficial, cutaneous, subcutaneous, and systemic mycoses, including the tissues involved.

3. Differentiate the colonial morphology of yeasts and filamentous fungi (molds).

4. Define and differentiate anamorph, teleomorph, and synanamorph.

5. Describe three ways in which fungi reproduce.

6. List the media that should be used for optimal recovery of fungi, including their incubation requirements.

7. List the common antibacterial agents used in fungal media.

8. Explain and differentiate the characteristic colonial morphology of fungi, including topography (rugose, umbonate, verrucose), texture (cottony, velvety, glabrous, granular, wooly) and surface described (front, reverse).

9. Describe and differentiate the sexual and asexual reproduction of the Ascomycota.

10. Define and differentiate rapid, intermediate, and slow growth rates with regard to fungal reproduction and cultivation.

11. Describe the proper method of specimen collection for fungal cultures, including collection site, acceptability, processing, transport, and storage.

12. Give the advantages and disadvantages of using screw-capped culture tubes, compared with agar plates, in the laboratory.

13. Describe the chemical principle and methodologies used to identify fungi, including calcofluor white–potassium hydroxide preparations, hair perforation, cellophane (Scotch) tape preparations, saline/wet mounts, lactophenol cotton blue, potassium hydroxide, Gram stain, India ink, modified acid-fast stain, periodic acid-Schiff stain (PAS), Wright’s stain, Papanicolaou stain, Grocott’s methenamine silver (GMS), hematoxylin and eosin (H&E) stain, Masson-Fontana stain, tease mount and microslide culture.

Mycology is a specialized discipline in the field of biology concerned with the study of fungi, including their taxonomy, environmental impact, and genetic and biochemical properties. Historically, the fungi were regarded as relatively insignificant causes of infection. However, in the early to mid-twentieth century, these microorganisms began to be recognized as important causes of disease, particularly because of changes in patient profiles, and this trend continues today. Because of the endemic systemic mycoses, which may cause disease in healthy hosts, a number of fungal species normally found in the environment have been recognized as important causes of human disease, particularly in the immunocompromised host. The modern clinical laboratory, therefore, must provide methods for isolating and identifying the common causes of mycologic disease. Susceptibility testing of these isolates is often necessary.

Some clinical microbiology laboratories have kept pace with changing times and have developed more extensive mycologic testing methods. However, the economic constraints of the current health care environment have prevented other laboratories from offering these services. In such cases, diagnostic clinical mycology is performed by reference laboratories, which have varying degrees of experience. The lack of experience in clinical mycology has been influenced by a shortage of trained individuals, lack of quality educational programs, and inability of clinical laboratories to support the cost of sending personnel to training courses. Commonly, individuals with experience who retire or leave their position are replaced by someone with considerably less experience. Training and continuing education programs are needed to assist in the development of such individuals, if quality laboratory services are to be offered. A real concern is that the changing health care environment and implementation of cost containment measures, without continuing education, will prevent future generations from being well trained in diagnostic clinical mycology.

This chapter is designed to assist technologists and microbiologists with the basics of diagnostic clinical mycology, in the hope that the information will allow some laboratories to offer clinical mycology services.

Epidemiology

Fungal infections are an increasing threat to individuals. The number of nosocomial and community-acquired infections has increased dramatically. The major factors responsible for the increase in the number of fungal infections are alterations in the host, particularly the growing number of immunocompromised people. Whether caused by immunosuppressive agents or serious underlying diseases, these alterations may lead to infection by organisms normally nonpathogenic or part of the patient’s normal microbiota (i.e., normal flora). These infections may occur in patients with debilitating diseases, such as progressive infection with the human immunodeficiency virus (HIV) or diabetes mellitus, or in patients with impaired immunologic function resulting from corticosteroid or antimetabolite chemotherapy. Other common predisposing factors include complex surgical procedures and antibacterial therapy. More than 200,000 valid species of fungi exist, but only 100 to 150 species are generally recognized as causes of human disease, and approximately 25 species cause most human disease. Most of these organisms normally live a saprophytic existence (living on dead or decayed organic matter) in nature.

Fungal infections generally are not communicable in the usual sense, through person-to-person transmission. Humans become accidental hosts for fungi by inhaling spores or through the introduction of fungal elements into tissue by trauma. Except for disease caused by the dimorphic fungi, humans are relatively resistant to infections caused by fungi. Classic infections are now appearing in new forms in patients, and the old “harmless” saprophytic molds are now being implicated in serious diseases. This ability of normally saprophytic fungi to cause disease in the immunocompromised patient means that laboratories now must be able to identify and report a wide array of fungi.

The primary pathogens appear to have well-defined geographic locations. An example of this is the dimorphic fungi Coccidioides immitis. C. immitis is usually found only in the United States in the desert Southwest, northern Mexico, and Central America. Opportunistic pathogens such as Candida and Aspergillus spp. are found all over the world.

General Features of the Fungi

Fungi seen in the clinical laboratory generally can be categorized into two groups based on the appearance of the colonies formed. The yeasts produce moist, creamy, opaque or pasty colonies on media, whereas the filamentous fungi or molds (see Chapters 60 and 61) produce fluffy, cottony, woolly, or powdery colonies. Several systemic fungal pathogens exhibit either a yeast (or yeastlike) phase, and filamentous forms are referred to as dimorphic. When dimorphism is temperature dependent, the fungi are designated as thermally dimorphic. In general, these fungi produce a mold form at 25° to 30°C and a yeast form at 35° to 37°C under certain circumstances.

The medically important dimorphic fungi are Histoplasma capsulatum, Blastomyces dermatitidis, C. immitis, Paracoccidioides brasiliensis, Sporothrix schenckii, and Penicillium marneffei (see Chapter 60). C. immitis is not thermally dimorphic. Additionally, some of the medically important yeasts, particularly the Candida species, may produce yeasts forms, pseudohyphae, and/or true hyphae (see Chapter 62). Fungi that have more than one independent form or spore stage in their life cycle are called polymorphic fungi. The polymorphic features of this group of organisms are not temperature dependent.

Taxonomy of the Fungi

Fungi are composed of a vast array of organisms that are unique compared with plants and animals. Included among these are the mushrooms, rusts and smuts, molds and mildews, and yeasts. Despite their great variation in morphologic features, most fungi share the following characteristics:

Traditionally, the fungi have been categorized into four well-established phyla: Zygomycota, Ascomycota, Basidiomycota, and Deuteromycota. The previous phylum, Zygomycota, has contained a very diverse group of organisms. Until further distinction is resolved, the organisms have been divided into the phylum, Glomeromycota and subphylum, Mucoromycotina, and Entomophthoracortina. This diverse group of fungi includes organisms that produce sparsely septate hyphae and exhibit asexual reproduction by sporangiospores and sexual reproduction by the production of zygospores. Some of the clinically important genera in this phylum are Rhizopus, Mucor, Rhizomucor, Absidia, and Cunninghamella.

The Ascomycota include many fungi that reproduce asexually by the formation of conidia (asexual spores) and sexually by the production of ascospores. The filamentous ascomycetes are ubiquitous in nature, and all produce true septate hyphae. All exhibit a sexual form (teleomorph) but also exist in an asexual form (anamorph). Fungi that have different asexual forms of the same fungus are called synanomorphs. In general, the anamorphic form correlates well with the teleomorphic classification. However, different anamorphic forms may have the same teleomorphic form. For example, Pseudallescheria boydii (Figure 59-1), in addition to having the Scedosporium apiospermum anamorph (Figure 59-2), may exhibit a Graphium anamorph (Figure 59-3). The latter anamorph may be seen with several other fungi.

An example of another clinically important fungi that belong to the phylum Ascomycota is H. capsulatum, which has a teleomorph designated as Ajellomyces. Some species of Aspergillus have a teleomorph, Eurotium.

Numerous yeast species also belong to the Ascomycota; these include Saccharomyces spp. and some species of Candida.

The phylum Basidiomycota includes fungi that reproduce sexually through the formation of basidiospores on a specialized structure called the basidia. The basidiomycetes are generally plant pathogens or environmental organisms that rarely cause disease in humans. This group includes smuts, rusts, mushrooms, and Cryptococcus neoformans complex. The teleomorphic form of C. neoformans is Filobasidiella neoformans.

The phylum Deuteromycota includes fungi that lack a sexual reproductive cycle and are characterized by their asexual reproductive structures, primarily conidia. The organisms in this group may have sexual forms that have not yet been described. The medically important fungus, Blastomyces dermatitidis, is a dimorphic fungus that has not been assigned to a phylum and is therefore placed in the order, Incertae sedis until the taxonomic placement is resolved.

Clinical Classification of the Fungi

The botanic taxonomic schema for grouping the fungi has little value in a clinical microbiology laboratory. Table 59-1 is a simplified taxonomic schema illustrating the major groups of fungi.

TABLE 59-1

Phylogenetic Position of Medically Significant Fungi

Phylum/Class Order Genus/Species
Phylum Glomeromycota    
 Subphylum
 Mucormycotina
Mucorales Absidia
Cunninghamella
Mucor
Rhizopus
Syncephalastrum
 Subphylum
 Entomophthoromycotina
Entomophthorales Basidiobolus
Conidiobolus
Phylum Ascomycota    
 Dothideomycetes Capnodiales Cladosporium
Piedraia hortae
Dothideales
Pleosporales
Aureobasidium
Alternaria
Bipolaris
Curvularia
Drechslera
Exserohilum
Helminthosporium
Stemphylium
Ulocladium
Epicoccum
Phoma
 Saccharomycetes Saccharomycetales Endomyces (Geotrichum sp.)*
Kluyveromyces (Candida pseudotropicalis)*
Candida
Geotrichum
 Sordariomycetes Hypocreales Acremonium
Gliocladium
Fusarium
Scopulariopsis
Sepedonium
Trichoderma
Microascales Pseudallescheria boydii
Scedosporium prolificans
Sporothrix
Sordariales Madurella
Trichosphaeriales Nigrospora
 Eurotiomycetes Chaetothyriales Cladophialophora
Exophiala
Fonsecaea
Phialophora
Rhinocladiella
Eurotiales Emericella (Aspergillus nidulans)*
Aspergillus
Paecilomyces
Penicillium
Onygenales Ajellomyces (Histoplasma capsulatum, Blastomyces dermatitidis)*
Arthroderma (Trichophyton sp. and Microsporum sp.)*
Chrysosporium
Coccidioides
Epidermophyton
Histoplasma
Microsporum
Paracoccidioides
Trichophyton
Phylum Basidiomycota    
 Tremellomycetes Filobasidiales Filobasidium (Cryptococcus neoformans)*
Not assigned Incertae sidis Blastomyces

image

*When the sexual form is known.

Most commonly encountered as causes of infection.

Modified from the Catalogue of Life. November 20, 2012. http://www.catalogueoflife.org/col/browse/classification and Hibbet DS, Binder M, Bischoff JF, et al. A higher-level of classification of the fungi, Mycological Research, 509-547, 2007.

For clinicians, dividing the fungi into four categories of mycoses, according to the type of infection, is much more useful. The fungi are categorized as follows:

The superficial, or cutaneous, mycoses are fungal infections that involve the hair, skin, or nails without direct invasion of the deeper tissue. The fungi in this category include the dermatophytes (agents of ringworm, athlete’s foot) and agents of infections such as tinea, tinea nigra, and piedra. All of these infect keratinized tissues.

Some fungi cause infections that are confined to the subcutaneous tissue without dissemination to distant sites. Examples of subcutaneous infections include chromoblastomycosis, mycetoma, and phaeohyphomycotic cysts (see Chapter 61).

As traditionally defined, agents of systemic fungal infections include the genera Blastomyces, Coccidioides, Histoplasma, and Paracoccidioides. Infections caused by these organisms primarily involve the lungs but also may become widely disseminated and involve any organ system. P. marneffei, a geographically limited cause of systemic mycosis in a select patient population, may also be considered a part of this group.

Any of the fungi could be considered an opportunistic pathogen in the appropriate clinical setting. The list of uncommon fungi found to cause disease in humans expands every year. Fungi previously thought to be nonpathogenic may be the cause of infections. The infections these organisms cause occur primarily in patients with some type of compromise of the immune system. This may occur secondary to an underlying disease process, such as diabetes mellitus, or it may be caused by an immunosuppressive agent. Although any fungus potentially can cause disease in these patients, the most commonly encountered genera in this group are Aspergillus, Candida, and Cryptococcus, among others. All of these organisms may cause disseminated (systemic) disease. Some of the dematiaceous fungi may cause deeply invasive phaeohyphomycoses (i.e., produce brown-pigmented structures) in this patient population.

Classification by type of infection allows the clinician to attempt to categorize organisms in a logical fashion into groups having clinical relevance. Table 59-2 presents an example of a clinical classification of infections and their etiologic agents that is useful to clinicians.

TABLE 59-2

General Clinical Classification of Pathogenic Fungi

Cutaneous Subcutaneous Opportunistic Systemic

 

image

*Virtually any fungus may cause disease in a profoundly immunocompromised host.

Practical Working Schema

To assist individuals working in clinical microbiology laboratories with the identification of clinically important fungi, Koneman and Roberts1 have suggested a practical working scheme designed to do the following:

Table 59-3 presents these features. However, the table includes only organisms commonly seen in the clinical laboratory. With practice, most laboratorians should be able to recognize these on a day-to-day basis. For other, less commonly encountered fungi, the microbiologist must use a variety of texts that have photomicrographs, which can aid identification.

image

*Rudimentary hyphae may be present.

From Koneman EW, Roberts GD: Practical laboratory mycology, ed 3, Baltimore, 1985, Williams & Wilkins.

Use of the identification scheme just described requires examination of the fungal culture for the presence, absence, and number of septa. If the hyphae appear to be broad and predominantly nonseptate (i.e., cells are not separated by a septum or wall), zygomycetes should be considered. If the hyphae are septate, they must be examined further for the presence or absence of pigmentation. If a dark pigment is present in the hyphae, the organism is considered to be dematiaceous, and the conidia are then examined for their morphologic features and their arrangement on the hyphae. If the hyphae are nonpigmented, they are considered to be hyaline. The fungi are then examined for the type and the arrangement of the conidia produced. The molds are identified by recognition of their characteristic microscopic features (see Table 59-3). Murray2 has developed an expanded morphologic classification of medically important fungi based on general microscopic features and colonial morphology. The color pigmentation of colonies is presented as a useful diagnostic feature (Box 59-1).

Box 59-1

Phenotypic Classification of Medically Important Fungi

Thermally Monomorphic Molds

1. White, cream, or light gray surface; nonpigmented reverse

2. White, cream, beige, or light gray surface; yellow, orange, or reddish reverse (genera)

3. White cream, beige, or light gray surface; red to purple reverse (genera)

4. White, cream, beige, or light gray surface; brown reverse (genera)

5. White, cream, beige, or light gray surface; black reverse (genera)

6. Tan to brown surface

7. Yellow to orange surface (genera)

8. Pink to violet surface (genera)

9. Green surface; light reverse (genera)

10. Dark gray or black surface; light reverse (genera)

11. Green, dark gray, or black surface; dark reverse

From Murray PR: ASM pocket guide to clinical microbiology, vol 3, Washington, DC, 2004, ASM Press.

Pathogeneis and Spectrum of Disease

Fungal infection is caused by either primary pathogens or opportunistic pathogens. Infections caused by primary pathogens usually occur in immunocompetent hosts, are not always as virulent, and may lead to subclinical disease. Opportunistic pathogens infect immunocompromised hosts. Opportunistic pathogens include almost any fungus present in the environment. An increase in the number of opportunistic fungal infections in humans is due in large part to the immunocompromised nature of the host. However, certain factors, called virulence factors, make invading tissues and causing disease easier for these organisms. Some virulence factors have been known for years:

Most of the fungi exist in environmental niches as saprophytic organisms (Table 59-4). Perhaps the fungi that cause disease in humans have developed various mechanisms that allow them to establish disease in the human host. Table 59-5 describes the known or speculative virulence factors of the fungi known to be pathogenic for humans.

TABLE 59-4

Summary of Common Pathogens

Organism Natural Habitat Infectious Form Mode of Transmission Common Sites of Infection Clinical Form
Aspergillus spp. Ubiquitous, plants Conidia Inhalation Lungs, eyes, skin, nails Hyphae
Blastomyces dermatitidis Unknown(?), soil/wood Probably conidia Usually inhalation Lungs, skin, long bones Yeast
Candida spp. Human flora Yeast, pseudohyphae, and true hyphae Direct invasion/dissemination GI and GU tracts, nails, viscera, blood Yeast, pseudohyphae, and true hyphae
Coccidioides immitis Soil of many arid regions Arthroconidia Inhalation Lungs, skin, meninges Spherules, endospores
Cryptococcus neoformans complex Bird feces, soil Yeast* Inhalation Lungs, skin, meninges Yeast
Histoplasma capsulatum Bat and bird feces Conidia Inhalation Lungs, bone marrow, blood Yeast
Paracoccidioides brasiliensis (?)Soil, plants Conidia Inhalation/trauma Lungs, skin, mucous membranes Yeast
Sporothrix schenckii Soil, plants Conidia/hyphae Trauma/rarely inhalation Skin and lymphatics, lungs, meninges Yeast
Dermatophytes Human disease, animals, soil Conidia/hyphae Contact Skin, hair, or nails Hyphae

image

GI, Gastrointestinal; GU, genitourinary.

*Possibly the conidia of the teleomorphic stage (Filobasidiella neoformans).

Blastomyces dermatitidis
BAD-1 Coccidioides immitis Cryptococcus neoformans complex Dematiaceous fungi Histoplasma capsulatum Paracoccidioides brasiliensis Sporothrix schenckii

image

Laboratory Diagnosis

Collection, Transport, and Culturing of Clinical Specimens

The diagnosis of fungal infections depends entirely on the selection and collection of an appropriate clinical specimen for microscopic analysis and culture. Many fungal infections are similar clinically to mycobacterial infections, and often the same specimen is cultured for both fungi and mycobacteria. Many infections have a primary focus in the lungs; respiratory tract secretions are almost always included among the specimens selected for culture. It should be emphasized that dissemination to distant body sites may occur, and fungi may be recovered from nonrespiratory sites.

Proper collection of specimens and rapid transport to the clinical laboratory are crucial to the recovery of fungi. Specimens often contain not only the etiologic agent, but also contaminating bacteria or fungi that rapidly overgrow some of the slower-growing pathogenic fungi. The viability of fungi decreases over time. If processing will be delayed, specimens can be refrigerated for a short time, except for dermatologic specimens (skin, hair, nails), blood, and cerebrospinal fluid (CSF). Yeasts (e.g., Candida spp.) commonly are recovered on routine bacteriology media and fungal culture media. A few specific comments concerning specimen collection and culturing are included in this chapter.

Cerebrospinal Fluid

Cerebrospinal fluid collected for culture should be filtered through a 0.45-µm membrane filter attached to a sterile syringe. After filtration, the filter is removed and placed on the surface of an appropriate culture medium with the inoculum side down. Alternatively, the specimen may be centrifuged and the concentrated sediment used to inoculate the culture medium. Cultures should be examined daily. If plated using a filter, the filter should be moved to another location every other day. If less than 1 mL of specimen is submitted for culture, it should be centrifuged, and 1-drop aliquots of the sediment should be placed on several areas on the agar surface. Media used for the recovery of fungi from CSF should contain no antibacterial or antifungal agents. Once submitted to the laboratory, CSF specimens should be processed promptly. If prompt processing is not possible, samples should be kept at room temperature or placed in a 30°C incubator, because most organisms continue to replicate in this environment.

Blood

Disseminated fungal infections are more prevalent than previously recognized, and blood cultures provide an accurate method for determining the etiology in many instances. Currently several automated blood culture systems, including the BACTEC (Becton Dickinson, Sparks, Maryland), BacT/ALERT (bioMérieux, Durham, North Carolina), and VersaTREK (Thermo Scientific, TREK Diagnostics, Cleveland, OH), are adequate systems for the recovery of yeasts.

Laboratories that frequently recover dimorphic fungi from blood are encouraged to use the lysis-centrifugation system, the Isolator (Alere Inc, Waltham, MA). The Isolator has been proven optimal for the recovery of H. capsulatum and other filamentous fungi. With this system, red blood cells and white blood cells, which may contain the microorganisms, are lysed, and centrifugation concentrates the organisms before culturing. The concentrate is inoculated onto the surface of appropriate culture media, and most fungi are detected within the first 4 days of incubation. However, occasional isolates of H. capsulatum may require approximately 10 to 14 days for recovery. The optimal temperature for fungal blood cultures is 30°C, and the suggested incubation time is 21 days.

Tissue, Bone Marrow, and Sterile Body Fluids

All tissues should be processed before culturing by mincing or placement in a high speed laboratory blender. Stomacher Lab Blenders, which are commercially available from various manufacturers, express the cytoplasmic contents of cells using pressure exerted from the action of rapidly moving metal paddles against the tissue in a broth suspension. (Large portions of tissue should be cut into smaller pieces if the Stomacher is to be used for processing.) After processing, at least 1 mL of specimen should be spread onto the surface of appropriate culture media, and the cultures should be incubated at 30°C for 21 days (incubation may be extended if clinical suspicion of a mycotic disease is high). Tissue samples should be inoculated onto an agar surface (i.e., not just the broth used to assist in the dissolution of the tissue in the Stomacher).

Bone marrow may be placed directly onto the surface of appropriate culture media and incubated in the manner previously mentioned. Sterile body fluids should be concentrated by centrifugation before culturing, and at least 1 mL of specimen should be placed on the surface of appropriate culture media. An alternative is to place bone marrow and other body fluids in an Isolator tube and process it as a blood culture. All specimens should be cultured as soon as possible to ensure the recovery of fungi.

Culture Media and Incubation Requirements

A number of fungal culture media are satisfactory for use in the clinical microbiology laboratory (Table 59-6). Most are adequate for the recovery of fungi, and the selection usually is left up to the laboratory director. For optimal recovery, a battery of media should be used; the following are recommended:

TABLE 59-6

Fungal Culture Media: Indications for Use

Media Indications for Use Media Composition Mode of Action
Primary Recovery Media      
Brain-heart infusion agar Primary recovery of saprobic and pathogenic fungi Brain-heart infusion, enzymatic digest of animal tissue, enzymatic digest of casein; dextrose, sodium chloride The agar provides a rich medium for bacteria, yeast, and pathogenic fungi.
Brain-heart infusion agar with antibiotics Primary recovery of pathogenic fungi exclusive of dermatophytes Brain-heart infusion, enzymatic digest of animal tissue, enzymatic digest of casein; dextrose, sodium chloride, antibiotics The agar provides a rich medium for yeast and pathogenic fungi.
Brain-heart infusion biphasic blood culture bottles Recovery of fungi from blood Brain-heart infusion, peptone, glucose, disodium phosphate Enhances the recovery of yeasts in blood
Chromogenic agar Isolation and presumptive identification of yeast and filamentous fungi Chromopeptone
Glucose
Chromogen mix
Chloramphenicol
Chromogen mix contains substrates that react with enzymes produced by different organisms that result in the production of characteristic color changes.
Dermatophyte test medium Primary recovery of dermatophytes; recommended as screening medium only Dextrose, cycloheximide, gentamycin, chloramphenicol, phenol red Dermatophytes produce alkaline metabolites, which raise the pH and change the medium from red to yellow.
Inhibitory mold agar Primary recovery of pathogenic fungi exclusive of dermatophytes Chloramphenicol, casein, dextrose, starch, sodium phosphate, magnesium sulphate, sodium chloride, manganese sulphate Examine plates for growth. Chloramphenicol inhibits bacterial growth.
Potato flake agar Primary recovery of saprobic and pathogenic fungi Potato flakes, glucose, cycloheximide, chloramphenicol, bromthymol blue Growth is enhanced by a pH alkaline reaction of fungus. Chloramphenicol and antibiotics inhibit the growth of bacteria and nonpathogenic fungi.
Mycosel Primary recovery of dermatophytes Cycloheximide, chloramphenicol, dextrose Inhibits bacteria and saprophytic fungi
SABHI agar Primary recovery of saprobic and pathogenic fungi Sabourad dextrose, brain-heart infusion agar Isolates and enhances growth of pathogenic fungi
Yeast-extract phosphate agar Primary recovery of pathogenic fungi exclusive of dermatophytes Yeast extract, dipotassium phosphate, chloramphenicol Enhances the recovery of Blastomyces dermatitidis and Histoplasma capsulatum from contaminated specimens
Differential Test Media      
Ascospore agar Detection of ascospores in ascosporogenous yeasts (e.g., Saccharomyces spp.) Potassium acetate, yeast extract, dextrose Potassium acetate is necessary, and yeast extract increases the sporulation of yeasts.
Christensen’s urea agar Identification of Cryptococcus, Trichosporon, and Rhodotorula spp. 2% Urea, phenol red Produces urease and a change in the pH
Cornmeal agar with Tween 80 and trypan blue Identification of Candida albicans by chlamydospore production; identification of C. albicans by microscopic morphology Cornmeal, Tween 80, trypan blue Addition of Tween 80 enhances the production of chlamydospores, and the addition of trypan blue provides a contrasting background for observing the morphologic features of yeasts.
Cottonseed conversion agar Conversion of the dimorphic fungus B. dermatitidis from mold to yeast form Cottonseed meal, glucose Allows conversion to yeast phase within 3 days
Czapek’s agar Differential identification of Aspergillus spp. Sodium nitrate, sucrose, yeast extract Produces characteristic features of yeast and fungus
Niger seed agar (birdseed agar) Identification of Cryptococcus neoformans complex Guizotia abysinica seed, dextrose, chloramphenicol C. neoformans produces a brown pigment through metabolism of caffeic acid.
Nitrate reduction medium Detection of nitrate reduction to confirm Cryptococcus spp. Potassium nitrate, peptone, meal extract, sulfanilic acid, N,N-dimethyl-1-naphthylamine If the yeast produces nitrate reductase, a cherry red indicates a positive test result.
Potato dextrose agar Demonstration of pigment production by Trichophyton rubrum; preparation of microslide cultures and sporulation of dermatophytes Potato infusion, D(+) glucose
Note: Some laboratories use potato flake agar, because it may be more stable.
Carbohydrate and potato infusion promotes the growth of yeasts and molds, and the low pH partially inhibits bacterial growth.
Rice medium Identification of Microsporum audouinii White rice extract, polysorbate 80 Polysorbate 80 enhances chlamydospore formation by C. albicans.
Differentiates Microsporum canis, which grows well with a yellow pigment, from M. audouinii, which shows no growth.
Trichophyton agars 1-7 Identification of Trichophyton spp. Casamino acids, dextrose, monopotassium phosphate, magnesium sulphate, amino acids (e.g., inositol, thiamine), ammonium nitrate Trichophyton spp. may be differentiated by their growth in the presence of different amino acids.
Urea agar Detection of Cryptococcus spp.; differentiate Trichophyton mentagrophytes from T. rubrum; detection of Trichosporon spp. Peptone, dextrose, sodium chloride, monopotassium phosphate, urea, phenol red Urea provides a nitrogen source for organisms producing urease. Urease releases ammonia, which increases the pH and is indicated by a color change from red to yellow.
Yeast fermentation broth Identification of yeasts by determining fermentation Yeast extract, peptone, bromcresol purple, and a specific carbohydrate (e.g., dextrose, maltose, sucrose) Most yeasts produce acid, which is indicated by a change in the solution from purple to yellow as a positive fermenter.
Yeast nitrogen base agar Identification of yeasts by determining carbohydrate assimilation Ammonium sulphate, carbon source (e.g., glucose, sucrose, raffinose) Assimilation of carbon by yeast cells produces a positive result.

image

image

Agar plates or screw-capped agar tubes are satisfactory for the recovery of fungi; however, plates are preferred, because they provide better aeration of cultures, a large surface area for better isolation of colonies, and greater ease of handling by technologists when making microscopic preparations for examination. Agar tends to dehydrate during the extended incubation period required for fungal recovery, but this problem can be minimized by using culture dishes containing at least 40 mL of agar and placing them in a humidified incubator. Dishes should be opened and examined only in a certified biologic safety cabinet (BSC). Many laboratories discourage the use of culture dishes because of safety considerations; however, the advantages outweigh the disadvantages.

Compared with agar plates, screw-capped culture tubes are more easily stored, require less space for incubation, and are more easily handled. In addition, they have a lower dehydration rate, and laboratory workers believe cultures are less hazardous to handle when in tubes. However, disadvantages, such as relatively poor isolation of colonies, a reduced surface area for culturing, and a tendency to promote anaerobiosis, discourage routine use in most clinical microbiology laboratories. If culture tubes are used, the tube should be as large as possible to provide an adequate surface area for isolation. After inoculation, tubes should be placed in a horizontal position for at least 1 to 2 hours to allow the specimen to absorb to the agar surface and avoid settling at the bottom of the tube. Cotton-plugged tubes are unsatisfactory for fungal cultures.

Cultures should be incubated at room temperature, or preferably at 30°C, for 21 to 30 days before they are reported as negative. A relative humidity in the range of 40% to 50% can be achieved by placing an open pan of water in the incubator. Cultures should be examined at least three times weekly during incubation.

As previously mentioned, some clinical specimens are contaminated with bacteria or rapidly growing fungi or both, requiring the use of antifungal and antibacterial agents. The addition of 0.5 µg/mL of cycloheximide and 16 µg/mL of chloramphenicol to media traditionally has been advocated to inhibit the growth of contaminating molds and bacteria, respectively. However, better results have been achieved using a combination of 5 µg/mL of gentamicin and 16 µg/mL of chloramphenicol as antibacterial agents. Ciprofloxacin at a concentration of 5 µg/mL may be used.

Cycloheximide may be added to any of the media that contain or lack antibacterial antibiotics. However, if cycloheximide is included in the battery of culture media, a medium lacking this ingredient should also be included. Pathogenic fungi, such as C. neoformans complex, Candida krusei and other Candida spp., Trichosporon spp., P. boydii, and Aspergillus spp., are partially or completely inhibited by cycloheximide.

Although use of antibiotics in fungal culture media is necessary for optimal recovery of organisms, the use of decontamination and concentration methods advocated for the recovery of mycobacteria is not appropriate, because many fungi are killed by sodium hydroxide treatment.

Direct Microscopic Examination

Direct microscopic examination of clinical specimens has been used for many years; however, its usefulness should be reemphasized. Because the mission of a clinical microbiology laboratory is to provide a rapid and accurate diagnosis, the mycology laboratory can provide this service in many instances by direct examination (particularly the Gram stain) of the clinical specimen submitted for culture. Microbiologists are encouraged to become familiar with the diagnostic features of fungi commonly encountered in clinical specimens and to recognize them when stained by various dyes. This important procedure often can provide the first microbiologic proof of the etiology of disease in patients with fungal infection. This is the most rapid method currently available.

Tables 59-7 and 59-8 present the methods available for direct microscopic detection of fungi in clinical specimens and a summary of the characteristic microscopic features of each. Figure 59-4 presents photomicrographs of some of the fungi commonly seen in clinical specimens.

TABLE 59-7

Summary of Methods Available for Direct Microscopic Detection of Fungi in Clinical Specimens

Method Use Time Required Advantages Disadvantages
Acid-fast stain and partial acid-fast stain Detection of mycobacteria and Nocardia spp., respectively 12 min Detects Nocardia spp.* and some isolates of Blastomyces dermatitidis Tissue homogenates are difficult to observe because of background staining.
Auramine-rhodamine stain Detection of mycobacteria and Nocardia spp., respectively 10 min Excellent screening tool; sensitive and affordable Not as specific for acid-fast organisms as Ziehl-Neelsen stain
Calcofluor white stain Detection of fungi 1 min Can be mixed with KOH: detects fungi rapidly because of bright fluorescence Requires use of a fluorescence microscope; background fluorescence prominent, but fungi exhibit more intense fluorescence; vaginal secretions are difficult to interpret.
Gram stain Detection of bacteria 3 min Commonly performed on most clinical specimens submitted for bacteriology; detects most fungi. Some fungi stain well, but others (e.g., Cryptococcus spp.) show only stippling and stain weakly in some instances; some isolates of Nocardia spp. fail to stain or stain weakly.
India ink stain Detection of Cryptococcus neoformans in CSF 1 min Diagnostic of meningitis when positive in CSF Positive in fewer than 50% of cases of meningitis; not sensitive in non–HIV-infected patients
Lactophenol cotton blue wet mount Most widely used method of staining and observing fungi 1 min Lactic acid preserves structures; slides can be made permanent. Mechanical treatment dislodges fungal structures.
Potassium hydroxide Clearing of specimen to make fungi more readily visible 5 min; if clearing is not complete, an additional 5-10 min is necessary Rapid detection of fungal elements Requires experience, because background artifacts are often confusing; clearing of some specimens may require an extended time.
Masson-Fontana stain Examination of melanin pigment in fungal cell walls 1 hr, 10 min Aids differentiation of melanin and hemosiderin pigments Difficult to interpret when only rare granular staining is present
Methenamine silver stain Detection of fungi in histologic section 1 hr Best stain for detecting fungal elements Requires a specialized staining method that is not usually readily available to microbiology laboratories
Papanicolaou stain Examination of secretions for malignant cells 30 min Cytotechnologist can detect fungal elements. Fungal elements stain pink to blue.
Periodic acid-Schiff (PAS) stain Detection of fungi 20 min; 5 min additional if counterstain is used Stains fungal elements well; hyphae of molds and yeasts can be readily distinguished. Nocardia spp. do not stain well.
Saline wet mount Examination of fungal elements 1 min Quickly performed and cost-effective Specimen must be fresh; not all elements are visible with this preparation.
Wright’s stain Examination of bone marrow or peripheral blood smears 7 min Detects Histoplasma capsulatum and C. neoformans Most often used to detect H. capsulatum and C. neoformans complex in disseminated disease.

image

CSF, Cerebrospinal fluid; HIV, human immunodeficiency virus; KOH, potassium hydroxide.

*Partially acid-fast bacterium.

From Versalovic J: Manual of clinical microbiology, ed 10, Washington, DC, 2011, ASM Press.

TABLE 59-8

Summary of Characteristic Features of Fungi Seen in Direct Examination of Clinical Specimens

Morphologic Form Found in Specimens Organism Size Range (diameter, mm) Characteristic Features
Yeastlike Histoplasma capsulatum 2-5 Small; oval to round budding cells; often found clustered in histiocytes; difficult to detect when present in small numbers
Sporothrix schenckii 2-6 Small; oval to round to cigar shaped; single or multiple buds present; uncommonly seen in clinical specimens
Cryptococcus neoformans complex 2-15 Cells exhibit great variation in size; usually spherical but may be football shaped; buds single or multiple and “pinched off”; capsule may or may not be evident; occasionally, pseudohyphal forms with or without a capsule may be seen in exudates of cerebrospinal fluid
Malassezia furfur (in fungemia) 1.5-4.5 Small; bottle-shaped cells, buds separated from parent cell by a septum; emerge from a small collar
Blastomyces dermatitidis 8-15 Cells are usually large, double refractile when present; buds usually single; however, several may remain attached to parent cells; buds connected by a broad base
Paracoccidioides brasiliensis 5-60 Cells are usually large and are surrounded by smaller buds around the periphery (“mariner’s wheel appearance”); smaller cells may be present (2-5 µm) and resemble H. capsulatum; buds have “pinched-off” appearance
Spherules Coccidioides immitis 10-200 Spherules vary in size; some may contain endospores, others may be empty; adjacent spherules may resemble B. dermatitidis; endospores may resemble H. capsulatum but show no evidence of budding; spherules may produce multiple germ tubes if a direct preparation is kept in a moist chamber ≥24 hr
Rhinosporidium seeberi 6-300 Large, thick-walled sporangia containing sporangiospores are present; mature sporangia are larger than spherules of C. immitis; hyphae may be found in cavitary lesions
Yeast and pseudohyphae or hyphae Candida spp. except C. glabrata 5-10 (pseudohyphae) Cells usually exhibit single budding; pseudohyphae, when present, are constricted at the ends and remain attached like links of sausage; hyphae, when present, are septate
M. furfur (in tinea versicolor) 3-8 (yeast) 2.5-4 (hyphae) Short, curved hyphal elements are usually present, along with round yeast cells that retain their spherical shape in compacted clusters
Pauciseptate hyphae Mucorales: Mucor, Rhizopus, and other genera 10-30 Hyphae are large, ribbonlike, often fractured or twisted; occasional septa may be present; smaller hyphae are confused with those of Aspergillus spp., particularly A. flavus
Hyaline septate hyphae Dermatophytes, skin and nails 3-15 Hyaline, septate hyphae are commonly seen; chains of arthroconidia may be present
Hair 3-15 Arthroconidia on periphery of hair shaft producing a sheath indicate ectothrix infection; arthroconidia formed by fragmentation of hyphae in the hair shaft indicate endothrix infection
  3-15 Long hyphal filaments or channels in the hair shaft indicate favus hair infection
Aspergillus spp. 3-12 Hyphae are septate and exhibit dichotomous, 45-degree branching; larger hyphae, often disturbed, may resemble those of zygomycetes
Geotrichum spp. 4-12 Hyphae and rectangular arthroconidia are present and sometimes rounded; irregular forms may be present
Trichosporon spp. 2-4 by 8 Hyphae and rectangular arthroconidia are present and sometimes rounded; occasionally, blastoconidia may be present
Dematiaceous septate hyphae Bipolaris spp., Cladosporium spp., Curvularia spp., Drechslera spp., Exophiala spp., Exserohilum spp., Hortaea werneckii, Phialophora spp. 2-6 Dematiaceous polymorphous hyphae are seen; budding cells with single septa and chains of swollen rounded cells are often present; occasionally, aggregates may be present in infection caused by Phialophora and Exophiala spp.
Wangiella dermatitidis 1.5-5 Usually large numbers of frequently branched hyphae are present, along with budding cells
Sclerotic bodies Cladosporium carrionii
Fonsecaea compacta Fonsecaea pedrosoi Phialophora verrucosa Rhinocladiella aquaspersa
5-20 Brown, round to pleomorphic, thick-walled cells with transverse septations; commonly, cells contain two fission planes that form a tetrad of cells (sclerotic bodies)
Granules Acremonium
 A. falciforme
 A. kiliense
 A. recifei
200-300 White, soft granules without a cementlike matrix
Aspergillus
 A. nidulans
500-1000 Black, hard grains with a cementlike matrix at periphery
Curvularia
 C. geniculata
 C. lunata
65-160 White, soft granule without a cementlike matrix
Exophiala
 E. jeanselmei
200-300 Black, soft granules, vacuolated, without a cementlike matrix, made of dark hyphae and swollen cells
Fusarium
 F. moniliforme
200-500 White, soft granules without a cementlike matrix
 F. solani 300-600  
Leptosphaeria
 L. senegalensis
400-600 Black, hard granules with cementlike matrix present
 L. tompkinsii 500-1000 Periphery composed of polygonal swollen cells and center of a hyphal network
Madurella
 M. grisea
350-500 Black, soft granules without a cementlike matrix, periphery composed of polygonal swollen cells and center of a hyphal network
 M. mycetomatis 200-900 Black to brown, hard granules, two types: (1) rust brown, compact, filled with cementlike matrix; (2) deep brown, filled with numerous vesicles, 6-14 µm in diameter, cementlike matrix in periphery, central area of light-colored hyphae
Neotestudina
 N. rosatii
300-600 White, soft granules with cementlike matrix at periphery
Pseudallescheria
 P. boydii
200-300 White, soft granules composed of hyphae and swollen cells at periphery in cementlike matrix
Pyrenochaeta
 P. romeroi
300-600 Black, soft granules composed of polygonal swollen cells at periphery; center is network of hyphae; no cementlike matrix present

image

image

Traditionally, the potassium hydroxide preparation has been the recommended method for direct microscopic examination of specimens. However, the calcofluor white stain now is believed to be superior (see Procedure 59-1 on the Evolve site). Slides prepared by this method may be observed using fluorescent or bright-field microscopy, as is used for the potassium hydroxide preparation; the former is optimal, because fungal cells fluoresce.

Procedure 59-1   Calcofluor White–Potassium Hydroxide Preparation

Serodiagnosis

Currently no commercially available procedures exist for serologic diagnosis of most fungi. However, serology testing may be a useful tool with a select few organisms, such as Cryptococcus, Blastomyces, Histoplasma, and Aspergillus spp.

Antibody testing has proven useful but not for immunocompromised patients, who are incapable of producing a measurable humoral response. Acute and convalescent titers need to be monitored during treatment of the fungal infection.

Complement fixation (CF) is a sensitive method that is difficult to perform and interpret. It requires a delay in testing that extends from exposure to the onset of symptoms; consequently, detection of antibody can take 2 to 3 months. Cross reactions with other fungal antibodies can also be a problem.

Immunodiffusion testing is a simple, cost-effective procedure. Although it is 100% specific, it is relatively insensitive and is not used as a screening tool. This test also requires 2 to 3 weeks to become positive.

Enzyme immunoassays for both antibody and antigen have been used. These tests are also frequently negative in immunocompromised patients, especially early in the infection.

Molecular Detection

Molecular detection methods are becoming popular in all areas of clinical microbiology; however, none has been accepted as a routine diagnostic tool in clinical mycology. Ideally, a panel of primers specific for the detection of fungi in clinical specimens would include the most common organisms known to cause disease in immunocompromised patients (including the dimorphic fungi and Pneumocystis jiroveci). However, currently no commercial methods are available to the clinical laboratory, and reports in the literature deal predominantly with selected organisms such as the Advan Dx PNA fish for the identification of Cardida spp. from blood cultures (Advan Dx, Woburn, MA). The large number of fungi may limit the development of a cost-effective screening method. Studies by Hopfer,4 Lu et al.,5 Makimura et al.,6 and Sandhu et al.7 present examples of what has been done with molecular methods in mycology for the detection of fungi in clinical specimens.

General Considerations for the Identification of Yeasts

Most often yeasts are identified through the use of a combination of tests (Figure 59-5). Identification factors and techniques include:

Several key characteristics can be seen macroscopically. Colonies have a wide variety of colors, shapes, and textures. Chromogenic agar can be used to differentiate yeast presumptively. Wet preps and lactophenol cotton blue stain can aid microscopic identification by improving the visualization of spore structure. Sexual and asexual characteristics are very important. Often a genus can be determined by the microscopic and macroscopic characteristics alone. India ink stain is useful when Cryptococcus organisms are suspected. Because carbon and nitrogen source differences are the key to differentiating yeasts, many automated and semiautomated commercial systems have been designed with assimilation and fermentation tests. Supplemental testing takes advantage of restriction of a limited set of characteristics to further aid identification.

General Considerations for the Identification of Molds

Filamentous fungi are also identified by a combination of tests (Figure 59-6). Molds are identified using a combination of the following:

In most cases the microscopic morphologic features provide the most definitive means of identification. Determination of the growth rate can be most helpful when a mold culture is examined. However, this may have limited value, because the growth rate of certain fungi varies, depending on the amount of inoculum present in a clinical specimen. Slow-growers form mature colonies in 11 to 21 days, and intermediate-growers form mature colonies in 6 to 10 days. Rapid-growers form mature colonies in 5 days or less.

The growth of C. immitis is often rapid and is hazardous to microbiologists. In general, the growth rate for the dimorphic fungi, B. dermatitidis, H. capsulatum, and P. brasiliensis, is slow; 1 to 4 weeks usually are required before colonies become visible. In some instances, cultures of B. dermatitidis and H. capsulatum may be detected within 3 to 5 days. This is a somewhat uncommon circumstance, encountered only when large numbers of the organism are present in the specimen. Colonies of Mucorales may appear within 24 hours, whereas the other hyaline and dematiaceous (melanized) fungi often exhibit growth in 1 to 5 days. The growth rate of an organism, therefore, is important, but it must be used in combination with other features before a definitive identification can be made.

The colonial morphologic features may have limited value for identifying molds because of natural variation among isolates and colonies grown on different culture media. Although common organisms recovered repeatedly in the laboratory may be more easily recognized, colonial morphology is an unreliable criterion that should be used only to supplement the microscopic morphologic features of the organism.

The color of the colony can be important. The examiner must be sure to notice both the front and reverse sides of the culture. The colony topography describes the various elevations of the colony on the agar plate. Topography can be described as verrucose (furrowed or convoluted), umbonate (slightly raised in the center), and rugose (furrows radiate out from the center).

The colony’s texture should also be noted. Various textures can be seen, such as cottony (loose, high aerial mycelium), velvety (low aerial mycelium resembling a velvet cloth), glabrous (smooth surface with no aerial mycelium), granular (dense, powdery, resembling sugar granules), and wooly (high aerial mycelium that appears slightly matted down).

Incubation conditions and culture media must also be considered. For example, H. capsulatum, which appears as a white-to-tan fluffy mold on brain-heart infusion agar, may have a yeastlike appearance when grown on the same medium containing blood enrichment.

In general, the microscopic morphologic features of the molds are stable and show minimal variation. Definitive identification is based on the characteristic shape, method of reproduction, and arrangement of spores; however, the size of the hyphae also provides helpful information. The large, ribbonlike, pauciseptate hyphae of the mucorales are easily recognized; small hyphae, approximately 2 µm in diameter, may suggest the presence of one of the dimorphic fungi or a dermatophyte.

The fungi may be prepared for microscopic observation using several techniques. The procedure traditionally used by most laboratories is the cellophane (Scotch) tape preparation (see Procedure 59-2 on the Evolve site; Figure 59-7). It can be done easily and quickly and often is sufficient to make the identification for most fungi. However, some laboratories prefer the wet mount (see Procedure 59-3 on the Evolve site; Figure 59-8) or tease mount (see Procedure 59-4 on the Evolve site). A microslide culture method (see Procedure 59-5 on the Evolve site; Figure 59-9) may be used when greater detail of the morphologic features is required.

Procedure 59-2   Cellophane (Scotch) Tape Preparation

Method

The transparent adhesive tape preparation allows the laboratorian to observe the organism microscopically approximately the way the fungi sporulates in culture. The relationship of the spores, spore-producing structures (e.g., conidiophores), and the body of the fungus are usually intact, and microscopic identification of an organism can be made easily. If the tape is not pressed firmly enough to the surface of the colony, the sample may consist only of conidia and may not be adequate for identification. When spores are not observed, a wet mount should be made. In some cases, the macroconidia of Histoplasma capsulatum have been seen in wet mount preparations when the adhesive tape preparation revealed only hyphal fragments. In other instances, cultures have sporulated and revealed only the presence of conidia when the adhesive tape preparation was observed. In this type of situation, a second adhesive tape preparation should be made from the periphery of the colony where sporulation is not as prominent.

Some laboratories prefer to use the microslide culture (see Procedure 59-5) for microscopic identification of an organism. This method might appear to be the most suitable, because it allows the examiner to observe microscopically the fungus growing directly underneath the coverslip. Microscopic features should be easily discerned, structures should be intact, and many representative areas of growth are available for observation.

Procedure 59-5   Microslide Culture

Method

1. Cut a small block of a suitable agar medium that has been previously poured into a culture dish to a depth of approximately 2 mm. The block may be cut using a sterile scalpel blade or with a sterile test tube that has no lip (which produces a round block).

2. Place a sterile microscope slide on the surface of a culture dish containing sterile 2% agar. Alternatively, place a round piece of filter paper or paper towel in a sterile culture dish, add two applicator sticks, and position the microscope slide on top.

3. Add the agar block to the surface of the sterile microscope slide.

4. With a right-angle wire, inoculate the four quadrants of the agar plug with the organism (Figure 59-9).

5. Apply a sterile coverslip to the surface of the agar plug.

6. If the filter paper applicator stick method is used, add a small amount of sterile water to the bottom of the culture dish. Replace the lid of the culture and allow it to incubate at 30°C.

7. After a suitable incubation period (and working inside a biologic safety cabinet), remove the coverslip and place it on a microscope slide containing a drop of lactophenol cotton or aniline blue. Some suggest placing the coverslip near the opening of an incinerator-burner to allow the organism to dry rapidly on the coverslip before adding it to the stain.

8. Observe microscopically for the characteristic shape and arrangement of spores.

9. If the microslide culture is unsatisfactory for microscopic identification, the remaining agar block may be used later if it is allowed to incubate further. The agar plug is then removed and discarded, and a drop of lactophenol cotton or aniline blue is placed on the area of growth and a coverslip is positioned in place. Many laboratorians like to make two cultures on the same slide so that if characteristic microscopic features are not observed on examination of the first culture, the second is available after an additional incubation period.

General Morphologic Features of the Molds

Specialized types of vegetative hyphae may be helpful for categorizing an organism into a certain group. For example, dermatophytes often produce several types of hyphae, including antler hyphae, so named because they are curved, freely branching, and have the appearance of antlers (Figure 59-10). Racquet hyphae are enlarged, club-shaped structures (Figure 59-11). In addition, certain dermatophytes produce spiral hyphae that are coiled or exhibit corkscrewlike turns in the hyphal strand (Figure 59-12). These structures are not characteristic for any certain group; however, they are found most commonly in dermatophytes.

Some species of fungi produce sexual spores in a large, saclike structure called an ascocarp (Figure 59-13). The ascocarp contains smaller sacs, called asci, each of which contains four to eight ascospores. This type of sexual reproduction is not commonly seen in the fungi recovered in the clinical microbiology laboratory; most exhibit only asexual reproduction. It is possible that all fungi have a sexual form, but for some species it has not yet been observed on artificial culture media. Conidia, which are produced by most fungi, represent the asexual reproductive cycle. The type of conidia and their morphology and arrangement are important criteria for definitively identifying an organism (Figure 59-14).

The simplest type of sporulation is the development of a spore directly from the vegetative hyphae. Arthroconidia are formed directly from the hyphae by fragmentation through the points of septation (Figure 59-15). When mature, they appear as square, rectangular, or barrel-shaped, thick-walled cells. These result from the simple fragmentation of the hyphae into spores, which are easily dislodged and disseminated into the environment. Chlamydoconidia (chlamydospores) are round, thick-walled spores formed directly from the differentiation of hyphae in which there is a concentration of protoplasm and nutrient material (Figure 59-16). These appear to be resistant resting spores produced by the rounding up and enlargement of the cells of the hyphae. Chlamydoconidia may be intercalary (within the hyphae) or terminal (on the end of the hyphae).

A variety of other types of spores occur with many species of fungi. Conidia are asexual spores produced singly or in groups by specialized hyphal strands, conidiophores. In some instances, the conidia are freed from their point of attachment by pinching off, or abstriction. Some conidiophores terminate in a swollen vesicle. From the surface of the vesicle are formed secondary small, flask-shaped phialides, which in turn give rise to long chains of conidia. This type of fruiting structure is characteristic of the aspergilli. A single, simple, slender, tubular conidiophore (phialide) that produces a cluster of conidia, held together as a gelatinous mass, is characteristic of certain fungi, including the genus Acremonium (Figure 59-17). In other instances, conidiophores form a branching structure called a penicillus, in which each branch terminates in secondary branches (metulae) and phialides, from which chains of conidia are borne (Figure 59-18). Species of Penicillium and Paecilomyces are representative of this type of sporulation. In other instances, fungi may produce conidia of two sizes: microconidia, which are small, unicellular, round, elliptical, or pyriform in shape, or macroconidia, which are large, usually multiseptate, and club or spindle shaped (Figure 59-19). Microconidia may be borne directly on the side of a hyphal strand or at the end of a conidiophore. Macroconidia are usually borne on a short to long conidiophore and may be smooth or rough walled. Microconidia and macroconidia are seen in some fungal species and are not specific, except as they are used to differentiate a limited number of genera.

The hyphae of the mucorales are sparsely septate. Sporulation takes place by progressive cleavage during maturation in the sporangium, a saclike structure produced at the tip of a long stalk (sporangiophore). Sporangiospores (spores produced in the sporangium) are produced and released by the rupture of the sporangial wall (Figure 59-20). In rare cases some isolates may produce zygospores, rough-walled spores produced by the union of two matching types of a mucorales; this is an example of sexual reproduction.

Clinical Relevance for Fungal Identification

The question of when and how far to go with the identification of fungi recovered from clinical specimens presents an interesting challenge. The current emphasis on cost containment and the ever-increasing number of opportunistic fungi causing infection in compromised patients prompts consideration of whether all fungi recovered from clinical specimens should be thoroughly identified and reported. A study by Murray et al.8 focused on the time and expense involved in identifying yeasts from respiratory tract specimens. Because these are the specimens most commonly submitted for fungal culture, the researchers questioned whether identifying every organism recovered was important. After evaluating the clinical usefulness of information provided through the identification of yeast recovered from respiratory tract specimens, they suggested the following:

The extent of identification of yeasts from other specimen sources is discussed in Chapter 63. The usefulness of identification and susceptibility testing of non-Cryptococcus yeast isolates was studied by Barenfenger.9 She found that, compared with only superficial characterization (i.e., “Yeast present, not C. neoformans), identification and susceptibility testing of Candida isolates from respiratory secretions led to unnecessary treatment and increased costs. No statistical difference was seen in the mortality of these groups.

When and how far to proceed in the identification of a mold is a difficult question to answer. Except for obvious plate contaminants, all commonly encountered molds should be identified and reported if recovered from patients at risk for invasive fungal disease. Immunocompromised patients may have serious or even fatal disease caused by fungi that were once thought to be clinically insignificant. Organisms that fail to sporulate after a reasonable time should be reported as present, but identification is not required if the dimorphic fungi have been ruled out or if the clinician believes the organism is not clinically significant. Ideally, all laboratories should identify all fungi recovered from clinical specimens; however, the limits of practicality and economic considerations play a definite role in the decision-making process. The laboratory director, in consultation with the clinicians being served, must make this decision after considering the patient population, laboratory practice, and economic impact.

As shown in Table 59-9, an increasing number of fungi may be isolated in the clinical microbiology laboratory. They are considered environmental flora, but in reality must be regarded as potential pathogens because infections with a number of these organisms have been reported. Less commonly encountered fungal pathogens that have been shown to cause human infections include but are not limited to P. boydii; Scedosporium prolificans; Bipolaris, Exserohilum, Trichosporon, and Aureobasidium spp., and others. The laboratory must identify and report all organisms recovered from clinical specimens so that their clinical significance can be determined. In many instances, the presence of environmental fungi is unimportant; however, that is not always the case. Tables 59-10 and 59-11 present the molds and yeasts implicated in causing human infection, the time required for their identification, the most likely site for their recovery, and the clinical implications of each.

TABLE 59-9

Fungi Most Commonly Recovered from Clinical Specimens

Blood Cerebrospinal Fluid Genitourinary Tract Respiratory Tract Skin
Candida albicans Cryptococcus neoformans Candida albicans Yeast, not Cryptococcus spp. Trichophyton rubrum
Candida tropicalis Candida albicans Candida glabrata Penicillium spp. Trichophyton mentagrophytes
Candida parapsilosis Candida parapsilosis Candida tropicalis Aspergillus spp. Alternaria spp.
Cryptococcus spp. Candida tropicalis Candida parapsilosis Aspergillus fumigatus Candida albicans
Histoplasma capsulatum Coccidioides immitis Penicillium spp. Cladosporium spp. Penicillium spp.
Candida lusitaniae Histoplasma capsulatum Candida krusei Alternaria spp. Scopulariopsis spp.
Candida krusei   Cryptococcus spp. Aspergillus niger Epidermophyton floccosum
Saccharomyces spp.   Saccharomyces spp. Geotrichum candidum Candida parapsilosis
Candida kefyr   Histoplasma capsulatum Fusarium spp. Aspergillus spp.
Candida zeylanoides   Cladosporium spp. Aspergillus versicolor Acremonium spp.
Trichosporon spp.   Aspergillus spp. Aspergillus flavus Aspergillus versicolor
Coccidioides immitis   Trichosporon spp. Acremonium spp. Cladosporium spp.
Candida guilliermondii   Alternaria spp. Scopulariopsis spp. Fusarium spp.
Malassezia furfur     Beauveria spp. Trichosporon spp.
      Trichosporon spp. Phialophora spp.

image

TABLE 59-10

Common Filamentous Fungi Implicated in Human Mycotic Infections

Etiologic Agent Time Required for Identification Probable Recovery Sites Clinical Implication
Acremonium spp. 2-6 days Skin, nails, respiratory secretions, cornea, vagina, gastric washings, blood Skin and nail infections, mycotic keratitis, mycetoma
Alternaria spp. 2-6 days Skin, nails, conjunctiva, respiratory secretions, subcutaneous tissue Skin and nail infections, sinusitis, conjunctivitis, hypersensitivity pneumonitis, skin abscess
Aspergillus flavus 1-4 days Skin, respiratory secretions, gastric washings, nasal sinuses, lung Skin infections, allergic bronchopulmonary infection, sinusitis, myocarditis, disseminated infection, renal infection, subcutaneous mycetoma
Aspergillus fumigatus 2-6 days Respiratory secretions, skin, ear, cornea, gastric washings, nasal sinuses, lung Allergic bronchopulmonary infection, fungus ball, invasive pulmonary infection, skin and nail infections, external otomycosis, mycotic keratitis, sinusitis, myocarditis, renal infection
Aspergillus niger 1-4 days Respiratory secretions, gastric washings, ear, skin Fungus ball, pulmonary infection, external otomycosis, mycotic keratitis
Aspergillus terreus 2-6 days Respiratory secretions, skin, gastric washings, nails, lung Pulmonary infection, disseminated infection, endocarditis, onychomycosis, allergic bronchopulmonary infection
Bipolaris spp. 2-6 days Respiratory secretions, skin, nose, bone, sinuses Sinusitis, brain abscess, peritonitis, subcutaneous abscess, pulmonary infection, osteomyelitis, encephalitis
Blastomyces dermatitidis 6-21 days (recovery time) (additional 1-2 days required for confirmatory identification) Respiratory secretions, skin, oropharyngeal ulcer, bone, prostate, lung Pulmonary infection, skin infection, oropharyngeal ulceration, osteomyelitis, prostatitis, arthritis, central nervous system (CNS) infection, disseminated infection
Cladosporium spp. 6-10 days Respiratory secretions, skin, nails, nose, cornea Skin and nail infections, mycotic keratitis, chromoblastomycosis caused by Cladophialophora carrionii
Coccidioides immitis 3-21 days Respiratory secretions, skin, bone, cerebrospinal fluid (CSF), synovial fluid, urine, gastric washings, blood Pulmonary infection, skin infection, osteomyelitis, meningitis, arthritis, disseminated infection
Curvularia spp. 2-6 days Respiratory secretions, cornea, brain, skin, nasal sinuses Pulmonary infection, disseminated infection, mycotic keratitis, brain abscess, mycetoma, endocarditis
Drechslera spp. 2-6 days Respiratory secretions, skin, peritoneal fluid (after dialysis) Pulmonary infection (rare)
Epidermophyton floccosum 7-10 days Skin, nails Tinea cruris, tinea pedis, tinea corporis, onychomycosis
Exophiala dermatitidis 5-21 days Respiratory secretions, skin, eye Phaeohyphomycosis, endophthalmitis, pneumonia
Exserohilum spp. 2-6 days Eye, skin, nose, bone Keratitis, subcutaneous abscess, sinusitis, endocarditis, osteomyelitis
Fusarium spp. 2-6 days Skin, respiratory secretions, cornea, nails, blood Mycotic keratitis, skin infection (in burn patients), disseminated infection, endophthalmitis
Geotrichum spp. 2-6 days Respiratory secretions, urine, skin, stool, vagina, conjunctiva, gastric washings, throat Bronchitis, skin infection, colitis, conjunctivitis, thrush, wound infection
Histoplasma capsulatum ≤10-45 days (recovery time) (additional 1-2 days required for confirmatory identification) Respiratory secretions, bone marrow, blood, urine, adrenals, skin, CSF, eye, pleural fluid, liver, spleen, oropharyngeal lesions, vagina, gastric washings, larynx Pulmonary infection, oropharyngeal lesions, CNS infection, skin infection (rare), uveitis, peritonitis, endocarditis, brain abscess, disseminated infection
Microsporum audouinii 10-14 days (recovery time) (additional 14-21 days required for confirmatory identification) Hair (scalp) Tinea capitis
Microsporum canis 5-7 days Hair, skin Tinea corporis, tinea capitis, tinea barbae, tinea manuum
Microsporum gypseum 3-6 days Hair, skin Tinea capitis, tinea corporis
Mucor spp. 1-5 days Respiratory secretions, skin, nose, brain, stool, orbit, cornea, vitreous humor, gastric washings, wounds, ear, lung Rhinocerebral infection, pulmonary infection, gastrointestinal infection, mycotic keratitis, intraocular infection, external otomycosis, orbital cellulitis, disseminated infection
Penicillium spp. 2-6 days Respiratory secretions, gastric washings, skin, urine, ear, cornea Allergy; human infections rare except with P. marneffei
Phialophora spp. 6-21 days Respiratory secretions, gastric washings, skin, cornea, conjunctiva Some species produce chromoblastomycosis or mycetoma; mycotic keratitis, conjunctivitis, intraocular infection
Pseudallescheria boydii 2-6 days Respiratory secretions, gastric washings, skin, cornea Pulmonary fungus ball, mycetoma, mycotic keratitis, endocarditis, disseminated infection, brain abscess
Rhizopus spp. 1-5 days Respiratory secretions, skin, nose, brain, stool, orbit, cornea, vitreous humor, gastric washings, wounds, ear, lung Rhinocerebral infection, pulmonary infection, mycotic keratitis, intraocular infection, orbital cellulitis, external otomycosis, disseminated infection
Scedosporium prolificans 2-6 days Respiratory secretions, skin, nasal sinuses, bone Arthritis, osteomyelitis, sinusitis, endocarditis
Scopulariopsis spp. 2-6 days Respiratory secretions, gastric washings, nails, skin, vitreous humor, ear Pulmonary infection, nail infection, skin infection, intraocular infection, external otomycosis
Sporothrix schenckii 3-12 days (recovery time) (additional 2-10 days required for confirmatory identification) Respiratory secretions, skin, subcutaneous tissue, maxillary sinuses, synovial fluid, bone marrow, bone, CSF, ear, conjunctiva Pulmonary infection, lymphocutaneous infection, sinusitis, arthritis, osteomyelitis, meningitis, external otomycosis, conjunctivitis, disseminated infection
Trichophyton mentagrophytes 7-10 days Hair, skin, nails Tinea barbae, tinea capitis, tinea corporis, tinea cruris, tinea pedis, onychomycosis
Trichophyton rubrum 10-14 days Hair, skin, nails Tinea pedis, onychomycosis, tinea corporis, tinea cruris
Trichophyton tonsurans 10-14 days Hair, skin, nails Tinea capitis, tinea corporis, onychomycosis, tinea pedis
Trichophyton verrucosum 10-18 days Hair, skin, nails Tinea capitis, tinea corporis, tinea barbae
Trichophyton violaceum 14-18 days Hair, skin, nails Tinea capitis, tinea corporis, onychomycosis

image

image

TABLE 59-11

Common Yeastlike Organisms Implicated in Human Infection*

Etiologic Agent Probable Recovery Sites Clinical Implication
Candida albicans Respiratory secretions, vagina, urine, skin, oropharynx, gastric washings, blood, stool, transtracheal aspiration, cornea, nails, cerebrospinal fluid (CSF), bone, peritoneal fluid Pulmonary infection, vaginitis, urinary tract infection, dermatitis, fungemia, mycotic keratitis, onychomycosis, meningitis, osteomyelitis, peritonitis, myocarditis, endocarditis, endophthalmitis, disseminated infection, thrush, arthritis
Candida glabrata Respiratory secretions, urine, vagina, gastric washings, blood, skin, oropharynx, transtracheal aspiration, stool, bone marrow, skin (rare) Pulmonary infection, urinary tract infection, vaginitis, fungemia, disseminated infection, endocarditis
Candida tropicalis Respiratory secretions, urine, gastric washings, vagina, blood, skin, oropharynx, transtracheal aspiration, stool, pleural fluid, peritoneal fluid, cornea Pulmonary infection, vaginitis, thrush, endophthalmitis, endocarditis, arthritis, peritonitis, mycotic keratitis, fungemia
Candida parapsilosis Respiratory secretions, urine, gastric washings, blood, vagina, oropharynx, skin, transtracheal aspiration, stool, pleural fluid, ear, nails Endophthalmitis, endocarditis, vaginitis, mycotic keratitis, external otomycosis, paronychia, fungemia
Saccharomyces spp. Respiratory secretions, urine, gastric washings, vagina, skin, oropharynx, transtracheal aspiration, stool, blood Pulmonary infection (rare), endocarditis
Candida krusei Respiratory secretions, urine, gastric washings, vagina, skin, oropharynx, blood, transtracheal aspiration, stool, cornea Endocarditis, vaginitis, urinary tract infection, mycotic keratitis
Candida guilliermondii Respiratory secretions, gastric washings, vagina, skin, nails, oropharynx, blood, cornea, bone, urine Endocarditis, fungemia, dermatitis, onychomycosis, mycotic keratitis, osteomyelitis, urinary tract infection
Rhodotorula spp. Respiratory secretions, urine, gastric washings, blood, vagina, skin, oropharynx, stool, CSF, cornea Fungemia, endocarditis, mycotic keratitis
Trichosporon spp. Respiratory secretions, blood, skin, oropharynx, stool Pulmonary infection, brain abscess, disseminated infection, piedra
Cryptococcus species complex (C. neoformans, var. neoformans; C. neoformans, var. grubii, C. gatti) Respiratory secretions, CSF, bone, blood, bone marrow, urine, skin, pleural fluid, gastric washings, transtracheal aspiration, cornea, orbit, vitreous humor Pulmonary infection, meningitis, osteomyelitis, fungemia, disseminated infection, endocarditis, skin infection, mycotic keratitis, orbital cellulitis, endophthalmic infection
Cryptococcus albidus subsp. albidus Respiratory secretions, skin, gastric washings, urine, cornea Meningitis, pulmonary infection
Candida kefyr (pseudotropicalis) Respiratory secretions, vagina, urine, gastric washings, oropharynx Vaginitis, urinary tract infection
Cryptococcus luteolus Respiratory secretions, skin, nose Not commonly implicated in human infection
Cryptococcus laurentii Respiratory secretions, CSF, skin, oropharynx, stool Not commonly implicated in human infection
Cryptococcus albidus subsp. diffluens Respiratory secretions, urine, CSF, gastric washings, skin Not commonly implicated in human infection
Cryptococcus terreus Respiratory secretions, skin, nose Not commonly implicated in human infection

Laboratory Safety

Although the handling of fungi recovered from clinical specimens poses risks, a common sense approach to the handling of these specimens protects the laboratory from contamination and workers from becoming infected.

Without exception, mold cultures and clinical specimens must be handled in a class II BSC. Some laboratory directors believe that mold cultures must be handled in an enclosed BSC equipped with gloves; however, this is not necessary if a laminar flow BSC is used. Yeast cultures may be handled on the bench top. An electric incinerator or a gas flame is suitable for decontaminating a loop used to transfer yeast cultures. Cultures of organisms suspected of being pathogens should be sealed with tape to prevent laboratory contamination and should be autoclaved as soon as the definitive identification is made. If common safety precautions are followed, few problems should occur with laboratory contamination or infection acquired by laboratory personnel.

Prevention

Preventing and controlling fungal infections continue to be a challenge to individuals, researchers, laboratorians, and hospitals. Very few formal recommendations are available to prevent exposure to community-acquired fungal infections. Good personal hygiene may be the best course for prevention. However, many strategies can be followed to prevent nosocomial infections. Hospital staff members should be aware of the pathogenesis of fungal infections. Fungi are easily spread in ventilation systems, water, and skin-to-skin contact. Hospitals should follow an infection control plan that includes periodic monitoring of air-handling systems and regular testing for environmental spores. Staff members, patients, and visitors should practice good personal hygiene to minimize exposure to potential fungal infections.

The laboratory also plays an important role in fungal prevention and control. Lack of rapid and specific testing continues to be a factor in a timely diagnosis. Early definitive diagnosis ensures that the appropriate therapy is given promptly and prevents mortality.